フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
GSK PLC 14 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC 13 January 2025 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a...
GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its " ...
GSK PLC 13 January 2025 Issued: 13 January 2025, London UK GSK enters agreement to acquire IDRx, Inc. · Acquisition includes IDRX-42, a...
GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. ...
GSK PLC 10 January 2025 Issued: 10 January 2025, London UK GSK's Shingrix new prefilled syringe presentation accepted for review by US FDA ...
GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treat ...
GSK PLC 07 January 2025 Issued: 7 January 2025, London UK GSK's B7-H3-targeted antibody-drug conjugate, GSK'227, receives US FDA...
GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sin ...
GSK PLC 03 January 2025 Issued: 3 January 2025, London UK GSK's Nucala (mepolizumab) approved in China for treatment of adults with chronic...
GSK PLC 02 January 2025 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す